Dose reduction of biologics in patients with plaque psoriasis: a review

• Main Authors: C. A. M. van Riel (Author), C. A. J. Michielsens (Author), M. E. van Muijen (Author), L. S. van der Schoot (Author), J. M. P. A. van den Reek (Author), E. M. G. J. de Jong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dose reduction (DR) of first-generation biologics for plaque psoriasis (TNF-alpha inhibitors (i) and interleukin (IL)-12/23i) has been described in a previous scoping review. The literature on the DR of the newest generation of biologics (IL-17/23i) was scarce. The current review provides a literatu...